The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Antibody Discovery Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Discovery of CAR-T Antibody Drugs
1.2.3 Discovery of Monoclonal Antibody Drugs
1.2.4 Discovery of ADC Antibody Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Therapeutic Antibody Discovery Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Antibody Discovery Services Market Perspective (2019-2030)
2.2 Therapeutic Antibody Discovery Services Growth Trends by Region
2.2.1 Global Therapeutic Antibody Discovery Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Therapeutic Antibody Discovery Services Historic Market Size by Region (2019-2024)
2.2.3 Therapeutic Antibody Discovery Services Forecasted Market Size by Region (2025-2030)
2.3 Therapeutic Antibody Discovery Services Market Dynamics
2.3.1 Therapeutic Antibody Discovery Services Industry Trends
2.3.2 Therapeutic Antibody Discovery Services Market Drivers
2.3.3 Therapeutic Antibody Discovery Services Market Challenges
2.3.4 Therapeutic Antibody Discovery Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Antibody Discovery Services Players by Revenue
3.1.1 Global Top Therapeutic Antibody Discovery Services Players by Revenue (2019-2024)
3.1.2 Global Therapeutic Antibody Discovery Services Revenue Market Share by Players (2019-2024)
3.2 Global Therapeutic Antibody Discovery Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Antibody Discovery Services Revenue
3.4 Global Therapeutic Antibody Discovery Services Market Concentration Ratio
3.4.1 Global Therapeutic Antibody Discovery Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Antibody Discovery Services Revenue in 2023
3.5 Therapeutic Antibody Discovery Services Key Players Head office and Area Served
3.6 Key Players Therapeutic Antibody Discovery Services Product Solution and Service
3.7 Date of Enter into Therapeutic Antibody Discovery Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Antibody Discovery Services Breakdown Data by Type
4.1 Global Therapeutic Antibody Discovery Services Historic Market Size by Type (2019-2024)
4.2 Global Therapeutic Antibody Discovery Services Forecasted Market Size by Type (2025-2030)
5 Therapeutic Antibody Discovery Services Breakdown Data by Application
5.1 Global Therapeutic Antibody Discovery Services Historic Market Size by Application (2019-2024)
5.2 Global Therapeutic Antibody Discovery Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Therapeutic Antibody Discovery Services Market Size (2019-2030)
6.2 North America Therapeutic Antibody Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Therapeutic Antibody Discovery Services Market Size by Country (2019-2024)
6.4 North America Therapeutic Antibody Discovery Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Antibody Discovery Services Market Size (2019-2030)
7.2 Europe Therapeutic Antibody Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Therapeutic Antibody Discovery Services Market Size by Country (2019-2024)
7.4 Europe Therapeutic Antibody Discovery Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Antibody Discovery Services Market Size (2019-2030)
8.2 Asia-Pacific Therapeutic Antibody Discovery Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Therapeutic Antibody Discovery Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Antibody Discovery Services Market Size (2019-2030)
9.2 Latin America Therapeutic Antibody Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Therapeutic Antibody Discovery Services Market Size by Country (2019-2024)
9.4 Latin America Therapeutic Antibody Discovery Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Antibody Discovery Services Market Size (2019-2030)
10.2 Middle East & Africa Therapeutic Antibody Discovery Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Therapeutic Antibody Discovery Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocytogen
11.1.1 Biocytogen Company Detail
11.1.2 Biocytogen Business Overview
11.1.3 Biocytogen Therapeutic Antibody Discovery Services Introduction
11.1.4 Biocytogen Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.1.5 Biocytogen Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Therapeutic Antibody Discovery Services Introduction
11.2.4 Charles River Laboratories Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.2.5 Charles River Laboratories Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Therapeutic Antibody Discovery Services Introduction
11.3.4 Abcam Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Alloy Therapeutics
11.4.1 Alloy Therapeutics Company Detail
11.4.2 Alloy Therapeutics Business Overview
11.4.3 Alloy Therapeutics Therapeutic Antibody Discovery Services Introduction
11.4.4 Alloy Therapeutics Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.4.5 Alloy Therapeutics Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Detail
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Therapeutic Antibody Discovery Services Introduction
11.5.4 Creative Biolabs Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.5.5 Creative Biolabs Recent Development
11.6 Twist Bioscience
11.6.1 Twist Bioscience Company Detail
11.6.2 Twist Bioscience Business Overview
11.6.3 Twist Bioscience Therapeutic Antibody Discovery Services Introduction
11.6.4 Twist Bioscience Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.6.5 Twist Bioscience Recent Development
11.7 Rapid Novor
11.7.1 Rapid Novor Company Detail
11.7.2 Rapid Novor Business Overview
11.7.3 Rapid Novor Therapeutic Antibody Discovery Services Introduction
11.7.4 Rapid Novor Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.7.5 Rapid Novor Recent Development
11.8 Curia
11.8.1 Curia Company Detail
11.8.2 Curia Business Overview
11.8.3 Curia Therapeutic Antibody Discovery Services Introduction
11.8.4 Curia Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.8.5 Curia Recent Development
11.9 AlivaMab Biologics
11.9.1 AlivaMab Biologics Company Detail
11.9.2 AlivaMab Biologics Business Overview
11.9.3 AlivaMab Biologics Therapeutic Antibody Discovery Services Introduction
11.9.4 AlivaMab Biologics Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.9.5 AlivaMab Biologics Recent Development
11.10 Integrated DNA Technologies
11.10.1 Integrated DNA Technologies Company Detail
11.10.2 Integrated DNA Technologies Business Overview
11.10.3 Integrated DNA Technologies Therapeutic Antibody Discovery Services Introduction
11.10.4 Integrated DNA Technologies Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.10.5 Integrated DNA Technologies Recent Development
11.11 Antibody Solutions
11.11.1 Antibody Solutions Company Detail
11.11.2 Antibody Solutions Business Overview
11.11.3 Antibody Solutions Therapeutic Antibody Discovery Services Introduction
11.11.4 Antibody Solutions Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.11.5 Antibody Solutions Recent Development
11.12 Eurofins Discovery
11.12.1 Eurofins Discovery Company Detail
11.12.2 Eurofins Discovery Business Overview
11.12.3 Eurofins Discovery Therapeutic Antibody Discovery Services Introduction
11.12.4 Eurofins Discovery Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.12.5 Eurofins Discovery Recent Development
11.13 GenScript
11.13.1 GenScript Company Detail
11.13.2 GenScript Business Overview
11.13.3 GenScript Therapeutic Antibody Discovery Services Introduction
11.13.4 GenScript Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.13.5 GenScript Recent Development
11.14 Evotec
11.14.1 Evotec Company Detail
11.14.2 Evotec Business Overview
11.14.3 Evotec Therapeutic Antibody Discovery Services Introduction
11.14.4 Evotec Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.14.5 Evotec Recent Development
11.15 Aurigene Pharmaceutical Services
11.15.1 Aurigene Pharmaceutical Services Company Detail
11.15.2 Aurigene Pharmaceutical Services Business Overview
11.15.3 Aurigene Pharmaceutical Services Therapeutic Antibody Discovery Services Introduction
11.15.4 Aurigene Pharmaceutical Services Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.15.5 Aurigene Pharmaceutical Services Recent Development
11.16 Yumab
11.16.1 Yumab Company Detail
11.16.2 Yumab Business Overview
11.16.3 Yumab Therapeutic Antibody Discovery Services Introduction
11.16.4 Yumab Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.16.5 Yumab Recent Development
11.17 Creative Bioarray
11.17.1 Creative Bioarray Company Detail
11.17.2 Creative Bioarray Business Overview
11.17.3 Creative Bioarray Therapeutic Antibody Discovery Services Introduction
11.17.4 Creative Bioarray Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.17.5 Creative Bioarray Recent Development
11.18 CD ComputaBio
11.18.1 CD ComputaBio Company Detail
11.18.2 CD ComputaBio Business Overview
11.18.3 CD ComputaBio Therapeutic Antibody Discovery Services Introduction
11.18.4 CD ComputaBio Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.18.5 CD ComputaBio Recent Development
11.19 Biomolecular Discovery Services
11.19.1 Biomolecular Discovery Services Company Detail
11.19.2 Biomolecular Discovery Services Business Overview
11.19.3 Biomolecular Discovery Services Therapeutic Antibody Discovery Services Introduction
11.19.4 Biomolecular Discovery Services Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.19.5 Biomolecular Discovery Services Recent Development
11.20 ProteoGenix
11.20.1 ProteoGenix Company Detail
11.20.2 ProteoGenix Business Overview
11.20.3 ProteoGenix Therapeutic Antibody Discovery Services Introduction
11.20.4 ProteoGenix Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.20.5 ProteoGenix Recent Development
11.21 Sichuan NB Biolab
11.21.1 Sichuan NB Biolab Company Detail
11.21.2 Sichuan NB Biolab Business Overview
11.21.3 Sichuan NB Biolab Therapeutic Antibody Discovery Services Introduction
11.21.4 Sichuan NB Biolab Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.21.5 Sichuan NB Biolab Recent Development
11.22 Viva Biotech
11.22.1 Viva Biotech Company Detail
11.22.2 Viva Biotech Business Overview
11.22.3 Viva Biotech Therapeutic Antibody Discovery Services Introduction
11.22.4 Viva Biotech Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.22.5 Viva Biotech Recent Development
11.23 SAFE Pharmaceutical Technology
11.23.1 SAFE Pharmaceutical Technology Company Detail
11.23.2 SAFE Pharmaceutical Technology Business Overview
11.23.3 SAFE Pharmaceutical Technology Therapeutic Antibody Discovery Services Introduction
11.23.4 SAFE Pharmaceutical Technology Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.23.5 SAFE Pharmaceutical Technology Recent Development
11.24 Shanghai Medicilon
11.24.1 Shanghai Medicilon Company Detail
11.24.2 Shanghai Medicilon Business Overview
11.24.3 Shanghai Medicilon Therapeutic Antibody Discovery Services Introduction
11.24.4 Shanghai Medicilon Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.24.5 Shanghai Medicilon Recent Development
11.25 WuXi Biologics
11.25.1 WuXi Biologics Company Detail
11.25.2 WuXi Biologics Business Overview
11.25.3 WuXi Biologics Therapeutic Antibody Discovery Services Introduction
11.25.4 WuXi Biologics Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.25.5 WuXi Biologics Recent Development
11.26 XtalPi
11.26.1 XtalPi Company Detail
11.26.2 XtalPi Business Overview
11.26.3 XtalPi Therapeutic Antibody Discovery Services Introduction
11.26.4 XtalPi Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.26.5 XtalPi Recent Development
11.27 Detaibio
11.27.1 Detaibio Company Detail
11.27.2 Detaibio Business Overview
11.27.3 Detaibio Therapeutic Antibody Discovery Services Introduction
11.27.4 Detaibio Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.27.5 Detaibio Recent Development
11.28 Cusabio
11.28.1 Cusabio Company Detail
11.28.2 Cusabio Business Overview
11.28.3 Cusabio Therapeutic Antibody Discovery Services Introduction
11.28.4 Cusabio Revenue in Therapeutic Antibody Discovery Services Business (2019-2024)
11.28.5 Cusabio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details